Intratumoral heterogeneity of intrahepatic cholangiocarcinoma

No personalized therapy regimens could demonstrate a benefit in survival of intrahepatic cholangiocarcinoma (iCCA). Since genetic heterogeneity might influence single biopsy based targeted therapy or the outcome of clinical trials, aim of the present study was to investigate intratumoral heterogenei...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Walter, Dirk, Döring, Claudia, Feldhahn, Magdalena, Battke, Florian, Hartmann, Sylvia, Winkelmann, Ria, Schneider, Markus, Bankov, Katrin, Schnitzbauer, Andreas, Zeuzem, Stefan, Hansmann, Martin Leo, Peveling-Oberhag, Jan
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2017
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5362457/
https://ncbi.nlm.nih.gov/pubmed/28146430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14844
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi